To mark JJDC’s 45th anniversary, GCV spoke to Asish Xavier and Renee Ryan, both vice-presidents for venture investments, who focus on biotech and medical devices respectively, and Stacy Feld, vice-president of consumer venture investments and external innovation.

JJDC has more experience than any healthcare corporate venturing division, with a legacy that stretches back to 1973. Its prominence has continued into 2018, with approximately 40 new and follow-on investments and more than $450m supplied globally, making it the leading healthcare CVC unit for disclosed investments over the past 12 months, according to deals…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.